{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:43Z","timestamp":1707524623386},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.7759\/cureus.27558","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T12:46:04Z","timestamp":1659357964000},"source":"Crossref","is-referenced-by-count":0,"title":["Delivery of Online Adaptive MRI-Guided Radiation Therapy for a Deaf Patient"],"prefix":"10.7759","author":[{"given":"Lauren C","family":"Linkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin J","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gage","family":"Redler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S","family":"Brohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan J","family":"Wuthrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2018.02.002","article-title":"Magnetic resonance imaging for target delineation and daily treatment modification","volume":"28","author":"Kashani R","year":"2018","unstructured":"Kashani R, Olsen JR. Magnetic resonance imaging for target delineation and daily treatment modification. Semin Radiat Oncol. 2018, 28:178-84. 10.1016\/j.semradonc.2018.02.002","journal-title":"Semin Radiat Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.05.048","article-title":"MR-guided gated stereotactic radiation therapy delivery for lung, adrenal, and pancreatic tumors: a geometric analysis","volume":"102","author":"van S\u00f6rnsen de Koste JR","year":"2018","unstructured":"van S\u00f6rnsen de Koste JR, Palacios MA, Bruynzeel AM, Slotman BJ, Senan S, Lagerwaard FJ. MR-guided gated stereotactic radiation therapy delivery for lung, adrenal, and pancreatic tumors: a geometric analysis. Int J Radiat Oncol Biol Phys. 2018, 102:858-66. 10.1016\/j.ijrobp.2018.05.048","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke L","year":"2018","unstructured":"Henke L, Kashani R, Robinson C, et al.. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiother Oncol. 2018, 126:519-26. 10.1016\/j.radonc.2017.11.032","journal-title":"Radiother Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0055","article-title":"Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Bichakjian CK","year":"2018","unstructured":"Bichakjian CK, Olencki T, Aasi SZ, et al.. Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018, 16:742-74. 10.6004\/jnccn.2018.0055","journal-title":"J Natl Compr Canc Netw"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens Y","year":"2020","unstructured":"Lievens Y, Guckenberger M, Gomez D, et al.. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiother Oncol. 2020, 148:157-66. 10.1016\/j.radonc.2020.04.003","journal-title":"Radiother Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma DA","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, et al.. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020, 38:2830-8. 10.1200\/JCO.20.00818","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2019.04.019","article-title":"The clinical introduction of MR-guided radiation therapy from a RTT perspective","volume":"18","author":"Botman R","year":"2019","unstructured":"Botman R, Tetar SU, Palacios MA, Slotman BJ, Lagerwaard FJ, Bruynzeel AM. The clinical introduction of MR-guided radiation therapy from a RTT perspective. Clin Transl Radiat Oncol. 2019, 18:140-5. 10.1016\/j.ctro.2019.04.019","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.02.007","article-title":"Assessing and providing culturally competent care in radiation oncology for deaf cancer patients","volume":"5","author":"Hill C","year":"2020","unstructured":"Hill C, Deville C, Alcorn S, Kiess A, Viswanathan A, Page B. Assessing and providing culturally competent care in radiation oncology for deaf cancer patients. Adv Radiat Oncol. 2020, 5:333-44. 10.1016\/j.adro.2020.02.007","journal-title":"Adv Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.06.002","article-title":"Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases","volume":"102","author":"Palacios MA","year":"2018","unstructured":"Palacios MA, Bohoudi O, Bruynzeel AM, et al.. Role of daily plan adaptation in MR-guided stereotactic ablative radiation therapy for adrenal metastases. Int J Radiat Oncol Biol Phys. 2018, 102:426-33. 10.1016\/j.ijrobp.2018.06.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.08.036","article-title":"Simulated online adaptive magnetic resonance-guided stereotactic body radiation therapy for the treatment of oligometastatic disease of the abdomen and central thorax: characterization of potential advantages","volume":"96","author":"Henke L","year":"2016","unstructured":"Henke L, Kashani R, Yang D, et al.. Simulated online adaptive magnetic resonance-guided stereotactic body radiation therapy for the treatment of oligometastatic disease of the abdomen and central thorax: characterization of potential advantages. Int J Radiat Oncol Biol Phys. 2016, 96:1078-86. 10.1016\/j.ijrobp.2016.08.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-258","article-title":"Medically inoperable Merkel cell carcinoma of the head and neck treated with stereotactic body radiation therapy: a case report","volume":"10","author":"Zhu JW","year":"2021","unstructured":"Zhu JW, Doerwald-Munoz L, Lee JW. Medically inoperable Merkel cell carcinoma of the head and neck treated with stereotactic body radiation therapy: a case report. Ann Palliat Med. 2021, 10:2354-8. 10.21037\/apm-20-258","journal-title":"Ann Palliat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0352-8","article-title":"In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series","volume":"6","author":"Xu MJ","year":"2018","unstructured":"Xu MJ, Wu S, Daud AI, Yu SS, Yom SS. In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series. J Immunother Cancer. 2018, 6:43. 10.1186\/s40425-018-0352-8","journal-title":"J Immunother Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/09687599727056","article-title":"Issues impacting on the governance of deafened adults","volume":"12","author":"Hogan E","year":"1997","unstructured":"Hogan E. Issues impacting on the governance of deafened adults. Disabil Soc. 1997, 12:789-801. 10.1080\/09687599727056","journal-title":"Disabil Soc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-018-1436-3","article-title":"Prostate-specimen antigen (PSA) screening and shared decision making among deaf and hearing male patients","volume":"35","author":"Kushalnagar P","year":"2020","unstructured":"Kushalnagar P, Hill C, Carrizales S, Sadler GR. Prostate-specimen antigen (PSA) screening and shared decision making among deaf and hearing male patients. J Cancer Educ. 2020, 35:28-35. 10.1007\/s13187-018-1436-3","journal-title":"J Cancer Educ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303299","article-title":"Prevalence of hearing loss by severity in the United States","volume":"106","author":"Goman AM","year":"2016","unstructured":"Goman AM, Lin FR. Prevalence of hearing loss by severity in the United States. Am J Public Health. 2016, 106:1820-2. 10.2105\/AJPH.2016.303299","journal-title":"Am J Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00011","article-title":"Communicating about health care: observations from persons who are deaf or hard of hearing","volume":"140","author":"Iezzoni LI","year":"2004","unstructured":"Iezzoni LI, O'Day BL, Killeen M, Harker H. Communicating about health care: observations from persons who are deaf or hard of hearing. Ann Intern Med. 2004, 140:356-62. 10.7326\/0003-4819-140-5-200403020-00011","journal-title":"Ann Intern Med"},{"key":"ref17","unstructured":"American's with Disabilities Act. Title III. (2010). Accessed: July 18, 2022: https:\/\/www.ada.gov\/taman3.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105930-delivery-of-online-adaptive-mri-guided-radiation-therapy-for-a-deaf-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:04Z","timestamp":1707508024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105930-delivery-of-online-adaptive-mri-guided-radiation-therapy-for-a-deaf-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.27558","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}